Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04742153Phase 2Unknown
A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC)
Advanced or Metastatic Breast Cancer
PrincipalinvestigatorStart date: 2021-05-13

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hebei Medical University Fourth Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hung T Khong, MD

University of Utah

Moderately Similar
1 trials

Shared therapeutic areas:

Advanced or Metastatic Breast Cancer
Similarity Score30%

François-Clément Bidard

Institut Curie

Moderately Similar
4 trials

Shared therapeutic areas:

Advanced or Metastatic Breast Cancer
Similarity Score30%

Wei Li, M.D.

The First Hospital of Jilin University

Moderately Similar
1 trials

Shared therapeutic areas:

Advanced or Metastatic Breast Cancer
Similarity Score30%

Yusha Zhu, MD PhD

Kind Pharmaceuticals LLC

Moderately Similar
4 trials

Shared therapeutic areas:

Advanced or Metastatic Breast Cancer
Similarity Score30%

Sibylle Loibl, MD, PhD

Prof., MD ASCO, ESGO, ESMO, DKG, DGGG, AGO, DGS, BIG, BCIRG, St. Gallen Faculty Member, SABCS Faculty member

Moderately Similar
1 trials

Shared therapeutic areas:

Advanced or Metastatic Breast Cancer
Similarity Score30%

Martine Piccart, MD PhD

Institute Jules Bordet - Boulevard De Waterloo 125 - B-1000 Brussels, Belgium

Moderately Similar
1 trials

Shared therapeutic areas:

Advanced or Metastatic Breast Cancer
Similarity Score30%

Udai Banerji, MD, PhD

Institute of Cancer Research, United Kingdom

Moderately Similar
2 trials

Shared therapeutic areas:

Advanced or Metastatic Breast Cancer
Similarity Score30%

Gaia Schiavon, MSD

AstraZeneca

Moderately Similar
1 trials

Shared therapeutic areas:

Advanced or Metastatic Breast Cancer
Similarity Score30%

Justin Lindemann, MBChB MBA

AstraZeneca

Moderately Similar
2 trials

Shared therapeutic areas:

Advanced or Metastatic Breast Cancer
Similarity Score30%

A. Jo Chien, MD

University of California, San Francisco

Moderately Similar
2 trials

Shared therapeutic areas:

Advanced or Metastatic Breast Cancer
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04742153Phase 2PrincipalInvestigator

A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC)

Advanced or Metastatic Breast Cancer
Unknown

All 1 trials loaded